Cargando…
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Background and Purpose: Mitragyna speciosa extract and kratom alkaloids decrease alcohol consumption in mice at least in part through actions at the δ-opioid receptor (δOR). However, the most potent opioidergic kratom alkaloid, 7-hydroxymitragynine, exhibits rewarding properties and hyperlocomotion...
Autores principales: | Gutridge, Anna M., Chakraborty, Soumen, Varga, Balazs R., Rhoda, Elizabeth S., French, Alexander R., Blaine, Arryn T., Royer, Quinten H., Cui, Haoyue, Yuan, Jinling, Cassell, Robert J., Szabó, Márk, Majumdar, Susruta, van Rijn, Richard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596301/ https://www.ncbi.nlm.nih.gov/pubmed/34803709 http://dx.doi.org/10.3389/fphar.2021.764885 |
Ejemplares similares
-
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
por: Gutridge, Anna M., et al.
Publicado: (2020) -
Biased Opioid Ligands
por: Faouzi, Abdelfattah, et al.
Publicado: (2020) -
Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose
por: Sharifi, Farrokh, et al.
Publicado: (2021) -
The Meta-Position of Phe(4) in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
por: Cassell, Robert J., et al.
Publicado: (2019) -
Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)